Amphion Innovations PLC Directors' Dealings (4145S)
24 September 2014 - 4:01PM
UK Regulatory
TIDMAMP
RNS Number : 4145S
Amphion Innovations PLC
24 September 2014
Directors' Dealings
Directors Receive Shares in Lieu of Fees
London and New York, 24 September 2014- Amphion Innovations plc
(the "Company") (LSE: AMP), the developer of medical and technology
businesses, announces that the Company has today issued 703,722
ordinary shares, representing 0.48% of the enlarged issued share
capital, to certain of its Board members as their directors' fees
for the third and fourth quarters of 2014, priced at 2.225 pence,
being the average of the closing mid-market price for the five days
leading up to the market close on 22 September 2014.Following this
issue, the directors' shareholdings in the Company are as
follows:
Director Number of New Shares Total Shareholding Percentage of voting rights
Miroslaw Izienicki 102,083 102,083 0.069%
R. James Macaleer 518,356 25,595,535 17.262%
Gerard Moufflet 83,333 1,039,583 0.701%
Admission of the 703,772 new ordinary shares, ranking pari passu
with the existing ordinary shares, is expected on 30 September
2014. Following this allotment the total issued share capital of
the Company will increase to 148,278,506 ordinary shares with each
share holding one voting right.
The Company has today granted options in respect of a further
7,000,000 Ordinary Shares at an issue price of 2.225 pence per
Ordinary Share to certain employees and Directors. Of the options
granted, 20% shall be exercisable from 31 December 2014, subject to
continuous service through that date; the remaining 80% will vest
rateably and monthly over four years from 1 September 2014. This
will include options in respect of 2,500,000 Ordinary Shares
granted to Richard Morgan, bringing his total options to 3,000,000
Ordinary Shares, and 2,500,000 to Robert Bertoldi, bringing his
total options to 2,850,000 Ordinary Shares.
For further information please contact
Amphion Innovations
Charlie Morgan
+1 212 210 6224
Novella Communications
Tim Robertson / Ben Heath
+44 020 3151 7008
Panmure Gordon Limited
Freddy Crossley / Fred Walsh / Duncan Monteith (Corporate
Finance)
Charlie Leigh-Pemberton (Corporate Broking)
+44 020 7886 2500
About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in emerging
companies in the medical and technology sectors, by using a
focused, hands-on company building approach, based on decades of
experience in both the US and UK. Amphion has significant
shareholding in 7 Partner Companies developing proven technologies
targeting substantial commercial marketplaces. The Amphion model
has been refined to optimise the commercialisation of patents and
other intellectual property within the Partner Companies. The
Partner Companies collectively own or control over 200 separately
identified pieces of intellectual property, a number which grows
rapidly each year.
On the web: www.amphionplc.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSPGUWCBUPCGCW
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From Apr 2024 to May 2024
Amphion Innovations (LSE:AMP)
Historical Stock Chart
From May 2023 to May 2024